Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004406 · ClinicalTrials.gov registry record · NA
Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT00004406 is a NA study that has completed, run by Columbia University. The registered enrollment target is 36 participants.
The verdict
NCT00004406, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Determine the effect of human parathyroid hormone (1-34) on bone mass in middle-aged men with idiopathic osteoporosis.
Interventions
- DRUG human parathyroid hormone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 1999-10 |
| Est. Completion | 2004-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004406
The ClinicalTrials.gov registry entry for NCT00004406 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which human parathyroid hormone is the first listed.
NCT00004406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004406 about?
NCT00004406 is a clinical study titled "Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis". OBJECTIVES: I. Determine the effect of human parathyroid hormone (1-34) on bone mass in middle-aged men with idiopathic osteoporosis.
What is the current status of trial NCT00004406?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 1999-10. Estimated completion is 2004-07.
What interventions are being tested in trial NCT00004406?
The interventions under investigation include: human parathyroid hormone (DRUG).
Who is sponsoring clinical trial NCT00004406?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.